from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1414/-

LFCtreatmentdescriptionclass of inhibitor

0.563

Amikacinug/mL Amikacintranslation

1.189

Cap5-10ug/mL Capreomycintranslation

-0.359

Rox10-50 ug/mL Roxithromycintranslation

0.047

SM2-5 ug/mL Streptomycintranslation

-0.880

Tet5-10 ug/mL Tetracyclinetranslation

0.278

Rif0.2-5ug/mL Rifampicintranscription

-0.694

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.929

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.155

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.092

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.119

Clofazimine10-13 ug/mL Clofaziminerespiration

0.063

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.443

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.860

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.669

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.929

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.148

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.095

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.318

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.377

KCN5-20 ug/mL Potassium cyaniderespiration

-0.075

NaN30.2-2 mM Sodium aziderespiration

-0.142

Nigericin50 uM Nigericinrespiration

0.056

TRC10-150 ug/mL Triclosanrespiration

0.392

TRZ10-25 ug/mL Thioridazinerespiration

2.069

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.236

menadione6-10 ug/mL Menadionerespiration

0.368

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.463

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.257

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.302

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.114

NRP_1Non-replicating persistence stage 1dosRassociated

-0.748

Amp0.2mg/mL AmpicillincellWall

0.091

Cephalexin20-100 ug/mL CephalexincellWall

0.856

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.099

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.590

EMB10-20 ug/mL EthambutolcellWall

-0.404

Eta12-40 ug/mL EthionamidecellWall

-0.511

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.360

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.604

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.198

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.968

BZA0.12 mg/mL BenzamidearomaticAmides

-0.432

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.636

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.474

H2O24 mM hydrogen peroxideDNAdamaging

-0.005

Levo10 ug/mL LevofloxacinDNAdamaging

-0.107

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.315

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.088

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.047

UVUV-irradiationDNAdamaging

0.009

ARP41-4 ug/mL Antitubercular compound ARP4?

0.089

Antimycin12.5-50 ug/mL Antimycin A?

0.672

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.152

PA_110-50 ug/mL Antitubercular compound PA-1?

0.579

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.649

PA8240.2-2 ug/mL PA-824?

0.300

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.390

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.043

Verapamil50 uM Verapamil?

-0.151

mercaptoethanol2 mM 2-Mercaptoethanol?

0.105

methoxatin10-20 ug/mL Methoxatin?